DRUG DISCOVERY
HIV AND AIDS
The Scripps Research Institute
The Scripps Research Institute does research pertaining to the human body and how it operates on every level. This institute contains "270 independent investigators, 700 postdoctoral fellows and 225 Ph.D. students". Because of this, The Scripps Research Institute has a good chance of finding a new treatment for HIV/AIDS.
The Scripps Research Institute
Established in 1996 by the Regents of the University of California, the AIDS Research Institute had a purpose to "coordinate the diverse AIDS research and clinical activities on the UCSD campus". The main goal of this institute is to become a center of research of HIV/AIDS and serving as a connection for AIDS researchers to create new ways to prevent, identify, and treat HIV/AIDS.
UC San Diego AIDS Research Institute
The Tufts and Brown Universities work in a combined research to bring together "all senior AIDS investigators" and has achieved success in the support of continuous research for HIV/AIDS. Leadership has gone international in the studies and training of collaborators and research at international sites.
Lifespan/Tufts/Brown Center for AIDS Research
Bristol-Myers Squibb has been focusing on patients whose needs are not met when dealing with chronic viral diseases. Also, Bristol-Myers Squibb distributes necessary resources to new medicines in progress and treatments to fight HIV/AIDS.
Bristol-Myers Squibb
The AIDS Research Alliance was made to eventually find and produce a cure for HIV/AIDS, preventing other infections and giving better treatments to those living a HIV-positive life. This company acknowledges a generation free of AIDS due to a vaccine that stops the spread of HIV and hopefully a cure.
AIDS Research Alliance
Similar to the AIDS Research Alliance, the Delaney AIDS Research Enterprise (DARE) is focused on finding a cure for HIV/AIDS. Those who work with DARE are "working to characterize reservoir sites where the HIV virus can persist beyond the reach of antiretroviral therapy". Researchers at DARE believe that a cure could be found by understanding the process of the continuance of viral reservoirs.
Delaney AIDS Research Enterprise
As the worldwide leader in research of HIV, its goal is to "understand, prevent, diagnose, and treat HIV infection and its many associated conditions". Funded researchers by NIH have helped to make, test, and show the effectiveness of antiretroviral drugs for treating the virus. These drugs have saved lives and changed how people live with HIV for the better.
The National Institutes of Health
ViiV was started in 2009 to talk about the worldwide HIV/AIDS needs. This company's primary focus is on children with HIV with five medicines going under investigation. Out of 36 research trials, 24 are researching mother-to-child transmission of HIV.
ViiV Healthcare
amfAR (American Foundation for AIDS Research) has invested millions of dollars and has given grants to research groups globally since 1985. This company was the first to introduce research that resulted in the use of antiretroviral drugs to prevent mother-to-child transmission of HIV. amfAR has helped to make treatment better for HIV infected people, continent wise.
amfAR
amfAR
Calimmmune was founded in 2007 and has been one of the main researchers relating to cell-based therapies in HIV/AIDS. At first, the company grew around stem cell research and technology discovered in early 2000. Calimmune's goal is to discover a way to cure people with HIV/AIDS in a successful and effective way.
Calimmune
